Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SABHA study

BACKGROUND: Hereditary angioedema with C1 inhibitor deficiency is a disabling, potentially fatal condition characterized by recurrent episodes of swelling. Self-treatment is recommended, in order to reduce admissions to the Emergency Room and the time between the onset of the attack and the treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanichelli, Andrea, Azin, Giulia Maria, Cristina, Federico, Vacchini, Romualdo, Caballero, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891972/
https://www.ncbi.nlm.nih.gov/pubmed/29631595
http://dx.doi.org/10.1186/s13023-018-0797-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891972/
https://www.ncbi.nlm.nih.gov/pubmed/29631595
http://dx.doi.org/10.1186/s13023-018-0797-3

Ejemplares similares